Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X ETF

127.05
+0.19000.15%
Pre-market: 126.03-1.0199-0.80%05:14 EDT
Volume:21.45K
Turnover:2.74M
Market Cap:171.52M
PE:- -
High:129.17
Open:127.20
Low:126.30
Close:126.86
52wk High:150.00
52wk Low:74.34
Shares:1.35M
Float Shares:1.35M
Volume Ratio:0.47
T/O Rate:1.59%
Dividend:1.26
Dividend Rate:0.99%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly

TIPRANKS
·
Aug 13

Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 12

Eli Lilly (LLY) Sues Six Companies Over Weight-Loss Drug Sales

TIPRANKS
·
Aug 12

Eli Lilly is Suing Pharmacies and Peptide Vendors over Sales of the Next Big Weight-Loss Drug: Retatrutide

Dow Jones
·
Aug 12

Amplifica Holdings Group: Closes Oversubscribed $26 Mln Series B Preferred Stock Financing Led by Tasso Partners, Participation from Eli Lilly & Co

THOMSON REUTERS
·
Aug 12

Dow Jones Top Company Headlines at 9 am ET: Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs | Brinker ...

Dow Jones
·
Aug 12

Eli Lilly Files Six Lawsuits Targeting Black-Market Retatrutide Sellers in US

Reuters
·
Aug 12

Lilly Calls on Online Platforms, Payment Companies and Regulators to Shut Down the Illegal Retatrutide Black Market

THOMSON REUTERS
·
Aug 12

Eli Lilly: Calling on Entities That Sellers Use to Conduct Their Illegal Business-Social Media and E-Commerce Platforms

THOMSON REUTERS
·
Aug 12

Eli Lilly - Reports over 14,000 Unlawful Retatrutide Listings in 100 Countries

THOMSON REUTERS
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11